CD105
Aliases: | END, HHT1, ORW1 |
---|---|
Other: | endoglin|CD105 antigen |
This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant m... see more
CF647
Common Laser: | 628-640 |
---|---|
Common Filter: | 660/20 |
Excitation Peak: | 650 |
Emission Peak: | 665 |
CF®647 from Biotium is a fluorophore with an excitation peak at 642 nm and an emission peak at 662 nm. It can be useful in both fluorescence microscopy and flow cytometry. It is spectrally similar to Alexa Fluor™ 647, DyLight™ 649 and Cy5.
Popular CD105 CF647 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Biotium BNC471326-500 |
IF,FC,WB | CD105 Human |
Mouse IgG1 ENG/1326 |
500 μl $399 |
Details | |
Biorbyt orb248879-CF647 |
ICC,IF | CD105 Human |
Mouse IgG1 CN4A3 |
100 &mu $534 |
Details | |
Biorbyt orb182932-CF647 |
ICC,IF | CD105 Human,Mouse,Rat |
Rabbit IgG |
100 ug $496 |
Details | |
Biorbyt orb101826-CF647 |
ICC,IF | CD105 Human,Mouse,Rat |
Rabbit IgG |
100 ug $479 |
Details | |
Biotium BNC471327-500 |
IF,FC,WB | CD105 Human |
Mouse IgG1 ENG/1327 |
500 μl $399 |
Details | |
Biorbyt orb10285-CF647 |
ICC,IF | CD105 Bovine,Canine,Equine,Chicken,Human,Mouse,Porcine,Rat |
Rabbit IgG |
100 ug $459 |
Details | |
Biorbyt orb312175-CF647 |
ICC,IF | CD105 Human,Mouse,Rat |
Rabbit IgG |
100 ug $479 |
Details | |
Biorbyt orb319440-CF647 |
ICC,IF | CD105 Human,Mouse,Rat |
Rabbit IgG |
100 ug $459 |
Details | |
Biotium BNC471327-100 |
IF,FC,WB | CD105 Human |
Mouse IgG1 ENG/1327 |
100 μl $120 |
Details | |
Biotium BNC471326-100 |
IF,FC,WB | CD105 Human |
Mouse IgG1 ENG/1326 |
100 μl $120 |
Details | |
Browse CD105 / CF647 antibodies. |